More Layoffs Hit Biogen as Drugmaker Cuts Multiple Sclerosis Team – NBC Boston
Biogen Wins US Approval for Drug to Treat Rare Form of ALS - BNN Bloomberg
Biogen and Novartis release Q1 earnings reports: Mixed results and hope for 2023
Personal Care Wipes - Hangzhou Biogen Hygiene Co., Ltd. - page 1.
Biogen Earnings Beat Expectations. All Eyes Are on the Alzheimer's Drug. | Barron's
Biogen (BIIB) Loses Bid to Revive Patent on Tecfidera MS Drug - Bloomberg
Biogen gears up Swiss manufacturing facility for potential aducanumab rollout | Fierce Pharma
Biogen begins cutting jobs following disastrous debut of its Alzheimer's drug - The Boston Globe
Biogen is ready to roll on lecanemab production, CFO says
Biogen and Alcyone Therapeutics partner up for novel device for neurological ASO therapies
Biogen gives up releasing Alzheimer's drug Aduhelm in Korea < Pharma < Article - KBR
Biogen targets 'lost to follow-up' patients in MS campaign - PMLiVE
Biogen Announces Positive Phase 1 Results, Plan to License and Develop Ionis Pharmaceuticals' Investigational Therapy BIIB067 for Familial ALS - Muscular Dystrophy Association
Biogen - Home | Facebook
Stocks making the biggest moves midday: Apple, Netflix, Biogen, Canopy Growth and more
Biogen's new CEO, clear-eyed about challenges, set to take reins
Biogen: Strong Prospects With A Low Valuation (NASDAQ:BIIB) | Seeking Alpha
For women, business as unusual at Biogen - The Boston Globe
What clinical trials of the future might look like | Biogen
Biogen teams up with Ginkgo Bioworks in gene therapy manufacturing pact - MedCity News
Biogen Seeks to Sublease Cambridge, Weston Properties - Banker & Tradesman
Biogen's ALS Drug Tofersen Gets Partial Backing From FDA Panel - Bloomberg
Biogen - Биоген - Photos | Facebook
Biogen, at a Crossroads, Surges on Promising Alzheimer's Drug Assessment - WSJ
CSRWire - Redefining What A Scientist Looks Like: Biogen Leaders Discuss the Importance of Women in STEM
Judge axes Biogen class action, rips shareholder lawyers for 'constant misrepresentation' | Reuters
